香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Beauty Farm Medical and Health Industry Inc. 美麗田園醫療健康產業有限公司 * （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：2373） 自願公告 市場股份回購 本公告由美麗田園醫療健康產業有限公司（「本公司」，連同其附屬公司統稱「本集 團」）自願刊發。 本公司董事（「董事」）會（「董事會」）認為，目前的股份成交價並不反映股份的內在價 值和本公司的實際業務前景。董事會相信，股份購回體現了管理層對企業長期價值 的堅定信心，有利於提升本集團資本市場價值及股東回報能力。本次股份購回符合 本公司及其股東的整體利益。 董事會本次回購是通過於2025年6月27日舉行的本公司股東週年大會（「股東週年大 會」）通過的股東（「股東」）決議案取得購回本公司股份（「股份」）的一般授權（「購回授 權」）進行。根據購回授權，本公司可購回最多23,579, ...

Core Viewpoint - Multiple companies, including China Feihe and Lianyi Rong Technology, conducted share buybacks on October 24, 2025, with China Feihe leading in both the number of shares repurchased and the total amount spent [1][2]. Group 1: Buyback Details - China Feihe (06186) repurchased 5.885 million shares for a total of 23.6977 million yuan, representing 0.087% of its total share capital [2]. - Lianyi Rong Technology (09959) repurchased 2.4 million shares for 7.3782 million yuan, accounting for 3.516% of its total share capital [2]. - Beike-W (02423) repurchased 1.1784 million shares for 7 million yuan, which is 1.722% of its total share capital [2]. Group 2: Other Notable Buybacks - Yum China (09987) repurchased 17,800 shares for 6.2549 million yuan, representing 2.830% of its total share capital [2]. - Mengniu Dairy (02319) repurchased 400,000 shares for 5.7447 million yuan, which is 0.545% of its total share capital [2]. - Kangsong Pharmaceutical (01681) repurchased 100,000 shares for 1.5180 million yuan, accounting for 8.582% of its total share capital [2].

Core Viewpoint - Meili Tianyuan Medical Health (02373) announced the repurchase of shares, indicating a strategic move to enhance shareholder value through buybacks [1] Summary by Categories Share Repurchase Details - The company repurchased 50,000 shares on October 24, 2025, for a total transaction amount of approximately HKD 1.5858 million, with an average price of about HKD 31.72 per share [1] - From October 15, 2025, to the date of the announcement, the company has repurchased a total of 375,000 shares at a total cost of approximately HKD 11.9808 million [1]

Core Viewpoint - Meili Tianyuan Medical Health (02373) has been actively repurchasing its shares, indicating a strategy to enhance shareholder value and confidence in the company's future prospects [1] Summary by Relevant Sections - **Share Buyback Activity** - The company repurchased 50,000 shares on October 24, 2025, for a total transaction amount of approximately HKD 1.5858 million, with an average price of about HKD 31.72 per share [1] - From October 15, 2025, to the date of the announcement, the company has repurchased a total of 375,000 shares at an aggregate cost of approximately HKD 11.9808 million [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 美麗田園醫療健康產業有限公司 呈交日期： 2025年10月24日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02373 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（ ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Beauty Farm Medical and Health Industry Inc. 美麗田園醫療健康產業有限公司 * （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：2373） 自願公告 市場股份回購 本公告由美麗田園醫療健康產業有限公司（「本公司」，連同其附屬公司統稱「本集 團」）自願刊發。 本公司欣然公佈，本公司於2025年10月24日於市場購回50,000股本公司股份，總交 易金額約1,585,810港元，交易平均價約每股31.72港元。自2025年10月15日至本公 告日期止期間，本公司已購回共375,000股股份，總對價約11,980,760港元。 * 僅供識別 – 1 – 本公司股東及有意投資者務請注意，購回股份由董事根據市場狀況全權決定進行， 且無法保證任何購回的時間、數量或價格。因此，本公司股東及有意投資者買賣本 公司證券時務請審慎行事。 承董事會命 ...

Core Viewpoint - Meili Tianyuan Medical Health (02373) has repurchased shares, indicating management's confidence in the company's long-term value and business prospects [1] Summary by Sections - **Share Repurchase Details** - The company repurchased 65,000 shares on October 23, 2025, for a total transaction amount of approximately HKD 1.9712 million, with an average price of about HKD 30.33 per share [1] - From October 15, 2025, to the date of the announcement, the company has repurchased a total of 325,000 shares at a total cost of approximately HKD 10.395 million [1] - **Management's Perspective** - The board believes that the current share price does not reflect the intrinsic value of the shares and the actual business outlook of the company [1] - The board is confident that the share repurchase demonstrates management's strong belief in the company's long-term value, which is beneficial for enhancing the group's market value and shareholder return capabilities [1] - The share repurchase aligns with the overall interests of the company and its shareholders [1]

Core Viewpoint - Meili Tianyuan Medical Health (02373.HK) announced a share buyback of 65,000 shares at a cost of HKD 1.97 million on October 23 [1] Summary by Category - **Company Actions** - The company executed a buyback of 65,000 shares, indicating a commitment to enhancing shareholder value [1] - The total expenditure for this buyback was HKD 1.97 million, reflecting the company's financial strategy [1]

Core Viewpoint - The company believes that the current share price does not reflect its intrinsic value and actual business prospects, indicating strong confidence in long-term value [1] Share Buyback Details - The company repurchased 65,000 shares on October 23, 2025, for a total transaction amount of approximately HKD 1.9712 million, with an average price of about HKD 30.33 per share [1] - From October 15, 2025, to the date of the announcement, the company has repurchased a total of 325,000 shares for an aggregate consideration of approximately HKD 10.395 million [1] Management's Perspective - The board of directors believes that the share buyback reflects management's firm confidence in the company's long-term value and is beneficial for enhancing the group's market value and shareholder return capability [1] - The buyback is considered to be in the overall interest of the company and its shareholders [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 美麗田園醫療健康產業有限公司 呈交日期： 2025年10月23日 (註7) (i) 上市發行人已收取其在是次股份發行或庫存股份出售或轉讓應得的全部款項； (viii) 有關債券、借貸股份、票據或公司債券的信託契約/平邊契據經已製備及簽署，有關詳情已送呈公司註冊處處長存檔（如法律如此規定）。 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02373 | 說明 | | ...